XML 108 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
12 Months Ended
Dec. 31, 2011
Segment Information [Abstract]  
Segment Information

Note 19—Segment Information

The Company currently operates within one "Specialty Pharmaceutical" segment which includes sales of KRYSTEXXA, Oxandrin and oxandrolone and the research and development activities of KRYSTEXXA.